Coloplast A/S Financials

Coloplast A/S Stock Summary

Coloplast A/S competes with GlucoTrack, Sharps Technology, Utah Medical, Innovative Eyewear, and Microbot Medical. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.

Coloplast A/S Key Financial Ratios

There are many critical financial ratios that Coloplast A/S's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Coloplast A/S reports annually and quarterly.

Coloplast Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Coloplast A/S's current stock value. Our valuation model uses many indicators to compare Coloplast A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Coloplast A/S competition to find correlations between indicators driving Coloplast A/S's intrinsic value. More Info.Coloplast AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.23  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Coloplast AS is roughly  4.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Coloplast A/S's earnings, one of the primary drivers of an investment's value.

Coloplast A/S Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Coloplast A/S help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Coloplast AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Coloplast AS based on widely used predictive technical indicators. In general, we focus on analyzing Coloplast Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Coloplast A/S's daily price indicators and compare them against related drivers.

When running Coloplast A/S's price analysis, check to measure Coloplast A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast A/S is operating at the current time. Most of Coloplast A/S's value examination focuses on studying past and present price action to predict the probability of Coloplast A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast A/S's price. Additionally, you may evaluate how the addition of Coloplast A/S to your portfolios can decrease your overall portfolio volatility.